₹ 14720 / 32 Shares Shares
Minimum Investment
₹438-460 per equity share
10 Dec 2025
12 Dec 2025
16
₹ 14720
₹438-460
17 Dec 2025
1,89,35,819 shares(aggregating up to ₹871.05 crore)
₹2 Per Equity Share
32 Shares
32 Shares
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
2010
Vikram Vuppala
Nephrocare Health Services Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹438-460 | ₹14,720 |
| Retail(max) | ₹438-460 | ₹1,91,360 |
| SHNI(min) | ₹438-460 | ₹2,06,080 |
| SHNI(max) | ₹438-460 | ₹9,86,240 |
| BHNI(min) | ₹438-460 | ₹10,00,960 |
Apply for all eligible candidates, Nephrocare Health Services Limited IPO.
NPS can offer higher returns due to market exposure, while PPF and EPF are safer but lower-yielding. It’s best to diversify.
A SIP is a disciplined investment method where you invest a fixed amount regularly in mutual funds to build wealth over time.
Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.
KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.
No, SIPs don’t guarantee returns but reduce risk over time and provide the potential for solid, market-linked growth.
Yes, KSquare allows you to pause, stop, or modify your SIP plan anytime through your account dashboard.
KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.
KSquare uses encrypted systems, regulatory safeguards, and secure servers to protect user data and transactions.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.